fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbroo...
FDA Recall #D-0020-2024 — Class II — September 21, 2023
Product Description
fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2
Reason for Recall
Lack of assurance of sterility:
Recalling Firm
Central Admixture Pharmacy Services Inc — San Diego, CA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
174, 5 mL syringes.
Distribution
Nationwide in the USA
Code Information
Lot:17-275479, Exp. 10/4/2023; 17-275852, Exp. 10/11/2023
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated